Clinical Trial Update: A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848 [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study of single and repeat doses of SB-480848 in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• SB-480848

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED